Text Size

Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes

This study has been completed.
Sponsor:
Collaborator:
Robert Wood Johnson Foundation
Information provided by (Responsible Party):
Kevin Fiscella, University of Rochester
ClinicalTrials.gov Identifier:
NCT00508014
First received: July 25, 2007
Last updated: November 30, 2011
Last verified: November 2011
History of Changes
  Purpose

We will assess the impact of concurrent peer review vists on blood pressure, cholesterol and diabetes control. Concurrent peer review (CPR) visits refer to special offic visits by patients to a clinician (physician, nurse practitioner, or physician assistant) other than than their primary care provider that are specifically designed to improve care for diabetes and cardiovascular disease.


Condition Intervention
Cardiovascular Diseases
 Other: Usual Care
Behavioral: Usual Care

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Concurrent Peer Review Visits to Reduce Cardiovascular Risk Factors

Resource links provided by NLM:

MedlinePlus related topics: Cholesterol Diabetes
U.S. FDA Resources

Further study details as provided by University of Rochester:

Primary Outcome Measures:
  • Mean change in blood pressure, glycated hemoglobin, and LDL-cholesterol between baseline and follow-up [ Time Frame: 7 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Use of aspirin, ACE inhibiters/ARBs (diabetic patients), pneumonia vaccine updated, diabetic foot exam, diabetic microalbumuria check, retinal exam, smoking cessation counseling, dental visit, and self management goal [ Time Frame: one year ] [ Designated as safety issue: No ]

Enrollment: 727
Study Start Date: December 2006
Study Completion Date: June 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
usual care
 Other: Usual Care
Usual Care with primary care provider during time period
Experimental: CPR visit
Receipt of CPR visit
 Behavioral: Usual Care
One CPR visit

Detailed Description:

This project aims to reduce racial and ethnic disparities in health care by improving cardiovascular and diabetes management among poor and minority patients. We propose to implement and evaluate an innovative, but practical intervention: CPR visits. CPR visits are designed to minimize competing demands for clinicians and reduce clinical inertia by focusing clinician and patient attention on optimizing cardiovascular and/or diabetes management and disease control and through use of clinician prompts and decision support at the point of care. Following training of clinician staff, CPR visits will be implemented within two sites of a single community health center (Westside Health Services, Inc). Patients will be randomly assigned one CPR visit with a clinician other than their primary care clinician or to usual care. The primary study outcome will include control of hypertension, diabetes, and lipids. Secondary outcomes will include process measures for cardiovascular and diabetes care. Both personnel and data collection infrastructure will build on the existing Health Disparities Collaborative at Westside. A research team from the University of Rochester will assist in the implementation of study design. This team will lead both the quantitative and qualitative evaluation of the project including outcome and process measures. Project findings offer promise for improving care to underserved populations through dissemination and implementation of a feasible strategy among practices caring for the underserved. Findings will be disseminated nationally in conjunction with the Robert Wood Johnson Foundation, the National Association of Community Health Centers, and the National Health Disparities Collaborative and through publication in the peer reviewed literature and presentation at national conferences.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Active patient at Westside Health Services.
  • Currently enrolled in the Health Disparities Collaborative at WHS.
  • At least one visit to primary care provider in past year.
  • Any of the following documented during the preceding three months:
  • BP not at goal e,g. (BP 140/80 or greater unless has DM, CAD or CRI then BP greater than 130/80), LDL-C not at goal (level dependent on absolute ATP III CVD risk) or glycated hemoglogin 7 percent or higher

Exclusion Criteria:

  • Less than 18 years of age
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00508014

Locations
United States, New York
Westside Health Services, Inc
Rochester, New York, United States, 14611
Sponsors and Collaborators
University of Rochester
Robert Wood Johnson Foundation
Investigators
Study Director: Kevin Fiscella, MD, MPH University of Rochester
  More Information

Additional Information:
Robert Wood Johnson Foundation Website on Grantees  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Kevin Fiscella, Tenured Professor, University of Rochester
ClinicalTrials.gov Identifier: NCT00508014     History of Changes
Other Study ID Numbers: 59768
Study First Received: July 25, 2007
Last Updated: November 30, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of Rochester:
Cardiovascular disease
Diabetes
Quality improvement
Peer review

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 22, 2013